#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Skin angiosarcoma Stiff person syndrome Myeloid leukaemia Adrenoleukodystrophy Metastatic gastric cancer Epidermolysis bullosa Bone marrow disorder Chemical burn Sjogren's syndrome Hyperphagia Mitochondrial encephalomyopathy Short-bowel syndrome Philadelphia positive chronic myeloid leukaemia Desmoid tumour More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Basic Information Lysosomal storage disorder – Basic Information Familial amyotrophic lateral sclerosis Progressive supranuclear palsy – Basic Information Congenital nephrogenic diabetes insipidus – Trials in Disease Glomerulonephritis membranous – Treatment Leiomyosarcoma metastatic – Basic Information Prolymphocytic leukaemia – Treatment Synovial sarcoma recurrent Optic glioma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lbl-007 Tocilizumab Sparsentan Etuvetidigene Autotemcel Clopidogrel Hydrogen Sulfate Cilgavimab POLYSORBATE 80 Omeprazole Ropivacaine Aluminium Oxide Saline Acou085 Avutometinib Gad20-209-Fsp-A2 Ribociclib Linagliptin ASP2957 Ruzasvir Itraconazole Gsk4381562A More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis I Bone marrow failure Pain in extremity Non-Hodgkin's lymphoma Partial seizures Angiosarcoma non-metastatic Diabetic retinopathy Herpes virus infection Hepatic cancer Respiratory failure Migraine Thromboangiitis obliterans Medulloblastoma recurrent Periodontitis Embolism venous More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Ezetimibe
    • Obicetrapib
    Czechia The Netherlands Slovakia

  • A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Connective tissue disorder
    • Dermatitis
    • Hidradenitis
    Investigated Drugs:
    • IMB 101
    • Sodium Chloride
    Bulgaria Germany Hungary Poland Romania

  • A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lebrikizumab
    Bulgaria France Germany Italy Poland Spain

  • A study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis

    Recruiting

    2 1 1
    France Germany Greece Italy Poland Spain

  • A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Capecitabine
    Austria Belgium Czechia France Germany Italy +5
Previous Page
1 … 643 644 645 646 647 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!